XML 102 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
GUARANTOR AND NON-GUARANTOR FINANCIAL INFORMATION (Tables)
9 Months Ended
Sep. 30, 2014
Guarantees [Abstract]  
Schedule of Condensed Balance Sheet
Condensed Consolidating Balance Sheets as at December 31, 2013    
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

ASSETS
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
19,461

 
$
5,422

 
$
78,741

 
$

 
$
103,624

Accounts receivable, net

 

 
174,081

 

 
174,081

Program rights, net

 

 
109,238

 

 
109,238

Other current assets
2,638

 
31

 
42,513

 

 
45,182

Assets held for sale

 

 
22,661

 

 
22,661

Intercompany current assets
53,396

 
2,052

 

 
(55,448
)
 

Total current assets
75,495

 
7,505

 
427,234

 
(55,448
)
 
454,786

Non-current assets
 

 
 

 
 
 
 
 
 
Investments in subsidiaries

 
479,435

 

 
(479,435
)
 

Property, plant and equipment, net

 

 
198,292

 

 
198,292

Program rights, net

 

 
288,344

 

 
288,344

Goodwill

 

 
782,870

 

 
782,870

Broadcast licenses and other intangible assets, net

 

 
223,815

 

 
223,815

Other non-current assets
3,976

 

 
9,790

 

 
13,766

Intercompany non-current assets
1,822,966

 
315,017

 
18,887

 
(2,156,870
)
 

Total non-current assets
1,826,942

 
794,452

 
1,521,998

 
(2,636,305
)
 
1,507,087

Total assets
$
1,902,437

 
$
801,957

 
$
1,949,232

 
$
(2,691,753
)
 
$
1,961,873

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
Accounts payable and accrued liabilities
$
18,234

 
$
41

 
$
272,102

 
$

 
$
290,377

Current portion of long-term debt and other financing arrangements

 
71

 
2,040

 

 
2,111

Other current liabilities
500

 

 
16,129

 

 
16,629

Liabilities held for sale

 

 
7,105

 

 
7,105

Intercompany current liabilities
7,788

 
45,988

 
1,672

 
(55,448
)
 

Total current liabilities
26,522

 
46,100

 
299,048

 
(55,448
)
 
316,222

Non-current liabilities
 

 
 

 
 
 
 
 
 
Deficiency in excess of investments in subsidiaries
296,351

 

 

 
(296,351
)
 

Long-term debt and other financing arrangements
620,375

 

 
342,568

 

 
962,943

Other non-current liabilities

 

 
33,817

 

 
33,817

Intercompany non-current liabilities
310,298

 
1,846,572

 

 
(2,156,870
)
 

Total non-current liabilities
1,227,024

 
1,846,572

 
376,385

 
(2,453,221
)
 
996,760

Temporary equity
207,890

 

 

 

 
207,890

Total equity / (deficit)
441,001

 
(1,090,715
)
 
1,273,799

 
(183,084
)
 
441,001

Total liabilities and equity
$
1,902,437

 
$
801,957

 
$
1,949,232

 
$
(2,691,753
)
 
$
1,961,873

Condensed Consolidating Balance Sheets as at September 30, 2014
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

ASSETS
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
3,963

 
$
1,425

 
$
67,293

 
$

 
$
72,681

Accounts receivable, net

 

 
130,106

 

 
130,106

Program rights, net

 

 
117,632

 

 
117,632

Other current assets
1,011

 
255

 
42,784

 

 
44,050

Assets held for sale

 

 
1,110

 

 
1,110

Intercompany current assets
8,185

 
34,049

 
32,774

 
(75,008
)
 

Total current assets
13,159

 
35,729

 
391,699

 
(75,008
)
 
365,579

Non-current assets
 
 
 
 
 
 
 
 
 
Investments in subsidiaries

 
501,235

 

 
(501,235
)
 

Property, plant and equipment, net

 

 
172,383

 

 
172,383

Program rights, net

 

 
248,276

 

 
248,276

Goodwill

 

 
714,824

 

 
714,824

Broadcast licenses and other intangible assets, net

 

 
194,997

 

 
194,997

Other non-current assets
48,858

 

 
8,854

 

 
57,712

Intercompany non-current assets
1,525,959

 
294,694

 
21,805

 
(1,842,458
)
 

Total non-current assets
1,574,817

 
795,929

 
1,361,139

 
(2,343,693
)
 
1,388,192

Total assets
$
1,587,976

 
$
831,658

 
$
1,752,838

 
$
(2,418,701
)
 
$
1,753,771

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
Accounts payable and accrued liabilities
$
8,558

 
$
253

 
$
213,343

 
$

 
$
222,154

Current portion of long-term debt and other financing arrangements

 

 
1,034

 

 
1,034

Other current liabilities
325

 

 
32,411

 

 
32,736

Liabilities held for sale

 

 
1,110

 

 
1,110

Intercompany current liabilities
2,752

 
32,624

 
39,632

 
(75,008
)
 

Total current liabilities
11,635

 
32,877

 
287,530

 
(75,008
)
 
257,034

Non-current liabilities
 

 
 

 
 
 
 
 
 
Deficiency in excess of investments in subsidiaries

135,062

 

 

 
(135,062
)
 

Long-term debt and other financing arrangements
493,921

 

 
311,918

 

 
805,839

Other non-current liabilities
24,833

 
500

 
38,199

 

 
63,532

Intercompany non-current liabilities
295,159

 
1,547,299

 

 
(1,842,458
)
 

Total non-current liabilities
948,975

 
1,547,799

 
350,117

 
(1,977,520
)
 
869,371

Temporary equity
219,770

 

 

 

 
219,770

Total equity / (deficit)
407,596

 
(749,018
)
 
1,115,191

 
(366,173
)
 
407,596

Total liabilities and equity
$
1,587,976

 
$
831,658

 
$
1,752,838

 
$
(2,418,701
)
 
$
1,753,771

Condensed Income Statement
Condensed Consolidating Statements of Operations for the nine months ended September 30, 2014
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net revenues
$

 
$

 
$
496,256

 
$

 
$
496,256

Cost of revenues

 

 
377,711

 

 
377,711

Selling, general and administrative expenses
12,713

 
1,135

 
96,446

 

 
110,294

Restructuring costs

 

 
8,628

 

 
8,628

Operating (loss) / income
(12,713
)
 
(1,135
)
 
13,471

 

 
(377
)
Interest income
106,842

 
20,905

 
337

 
(127,730
)
 
354

Interest expense
(101,104
)
 
(106,652
)
 
(24,086
)
 
127,730

 
(104,112
)
Loss on extinguishment of debt
(24,161
)
 

 

 

 
(24,161
)
Foreign currency exchange gain / (loss), net
4,761

 
(3,946
)
 
(7,225
)
 

 
(6,410
)
Change in fair value of derivatives
2,311

 
(5,579
)
 
5,579

 

 
2,311

Other expense, net

 

 
(1,746
)
 

 
(1,746
)
Loss from continuing operations before tax and loss from investment in subsidiaries
(24,064
)
 
(96,407
)
 
(13,670
)
 

 
(134,141
)
Credit / (provision) for income taxes

 
10,327

 
(11,275
)
 

 
(948
)
Loss from continuing operations before loss from investment in subsidiaries
(24,064
)
 
(86,080
)
 
(24,945
)
 

 
(135,089
)
Loss from investment in subsidiaries
(237,552
)
 
(30,929
)
 

 
268,481

 

Loss from continuing operations
(261,616
)
 
(117,009
)
 
(24,945
)
 
268,481

 
(135,089
)
Loss from discontinued operations, net of tax

 

 
(18,532
)
 

 
(18,532
)
Net loss
(261,616
)
 
(117,009
)
 
(43,477
)
 
268,481

 
(153,621
)
Net loss attributable to noncontrolling interests

 

 
1,130

 

 
1,130

Net loss attributable to CME Ltd.
(261,616
)
 
(117,009
)
 
(42,347
)
 
268,481

 
(152,491
)
Comprehensive loss attributable to CME Ltd.
$
(261,616
)
 
$
(237,552
)
 
$
(30,929
)
 
$
268,481

 
$
(261,616
)
Condensed Consolidating Statements of Operations for the nine months ended September 30, 2013
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net revenues
$

 
$

 
$
437,214

 
$

 
$
437,214

Cost of revenues

 

 
408,244

 

 
408,244

Selling, general and administrative expenses
25,361

 
2

 
78,104

 

 
103,467

Restructuring costs
742

 
24

 
8,124

 

 
8,890

Operating loss
(26,103
)
 
(26
)
 
(57,258
)
 

 
(83,387
)
Interest income
100,210

 
1,555

 
552

 
(101,738
)
 
579

Interest expense
(66,306
)
 
(87,441
)
 
(34,993
)
 
101,738

 
(87,002
)
Loss on extinguishment of debt
(23,115
)
 

 

 

 
(23,115
)
Foreign currency exchange gain / (loss), net
15,520

 
1,592

 
(8,206
)
 

 
8,906

Change in fair value of derivatives

 

 
104

 

 
104

Other expense, net

 

 
(657
)
 

 
(657
)
Income / (loss) from continuing operations before tax and loss on investment in subsidiaries
206

 
(84,320
)
 
(100,458
)
 

 
(184,572
)
Credit for income taxes

 
7,990

 
5,619

 

 
13,609

Income / (loss) from continuing operations before loss on investment in subsidiaries
206

 
(76,330
)
 
(94,839
)
 

 
(170,963
)
Loss on investment in subsidiaries
(181,301
)
 
(72,985
)
 

 
254,286

 

Loss from continuing operations
(181,095
)
 
(149,315
)
 
(94,839
)
 
254,286

 
(170,963
)
Loss from discontinued operations, net of tax

 

 
(2,361
)
 

 
(2,361
)
Net loss
(181,095
)
 
(149,315
)
 
(97,200
)
 
254,286

 
(173,324
)
Net loss attributable to noncontrolling interests

 

 
995

 

 
995

Net loss attributable to CME Ltd.
(181,095
)
 
(149,315
)
 
(96,205
)
 
254,286

 
(172,329
)
Comprehensive loss attributable to CME Ltd.
$
(181,095
)
 
$
(181,301
)
 
$
(72,985
)
 
$
254,286

 
$
(181,095
)
Condensed Consolidating Statements of Operations for the three months ended September 30, 2013
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net revenues
$

 
$

 
$
130,988

 
$

 
$
130,988

Cost of revenues

 

 
133,841

 

 
133,841

Selling, general and administrative expenses
14,702

 
1

 
22,185

 

 
36,888

Restructuring costs
742

 
24

 
3,426

 

 
4,192

Operating loss
(15,444
)
 
(25
)
 
(28,464
)
 

 
(43,933
)
Interest income
32,121

 
741

 
159

 
(32,855
)
 
166

Interest expense
(17,071
)
 
(29,064
)
 
(10,536
)
 
32,855

 
(23,816
)
Foreign currency exchange gain, net
36,176

 
956

 
6,579

 

 
43,711

Other expense, net

 

 
(232
)
 

 
(232
)
Income / (loss) from continuing operations before tax and loss on investment in subsidiaries
35,782

 
(27,392
)
 
(32,494
)
 

 
(24,104
)
Credit / (provision) for income taxes

 
2,416

 
(120
)
 

 
2,296

Income / (loss) from continuing operations before loss on investment in subsidiaries
35,782

 
(24,976
)
 
(32,614
)
 

 
(21,808
)
Loss on investment in subsidiaries
(58,646
)
 
(1,295
)
 

 
59,941

 

Loss from continuing operations
(22,864
)
 
(26,271
)
 
(32,614
)
 
59,941

 
(21,808
)
Loss from discontinued operations, net of tax

 

 
(1,465
)
 

 
(1,465
)
Net loss
(22,864
)
 
(26,271
)
 
(34,079
)
 
59,941

 
(23,273
)
Net loss attributable to noncontrolling interests

 

 
182

 

 
182

Net loss attributable to CME Ltd.
(22,864
)
 
(26,271
)
 
(33,897
)
 
59,941

 
(23,091
)
Comprehensive loss attributable to CME Ltd.
$
(22,864
)
 
$
(58,646
)
 
$
(1,295
)
 
$
59,941

 
$
(22,864
)
Condensed Consolidating Statements of Operations for the three months ended September 30, 2014
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net revenues
$

 
$

 
$
140,149

 
$

 
$
140,149

Cost of revenues

 

 
113,982

 

 
113,982

Selling, general and administrative expenses
3,757

 
608

 
30,100

 

 
34,465

Restructuring costs

 

 
342

 

 
342

Operating loss
(3,757
)
 
(608
)
 
(4,275
)
 

 
(8,640
)
Interest income
33,114

 
6,800

 
56

 
(39,911
)
 
59

Interest expense
(36,480
)
 
(33,046
)
 
(7,488
)
 
39,911

 
(37,103
)
Loss on extinguishment of debt

 

 

 

 

Foreign currency exchange gain / (loss), net
3,799

 
(224
)
 
(9,593
)
 

 
(6,018
)
Change in fair value of derivatives

 
(3,150
)
 
3,150

 

 

Other income, net

 

 
22

 

 
22

Loss from continuing operations before tax and loss from investment in subsidiaries
(3,324
)
 
(30,228
)
 
(18,128
)
 

 
(51,680
)
Credit / (provision) for income taxes

 
2,398

 
(3,056
)
 

 
(658
)
Loss from continuing operations before loss from investment in subsidiaries
(3,324
)
 
(27,830
)
 
(21,184
)
 

 
(52,338
)
Loss from investment in subsidiaries
(150,941
)
 
(2,381
)
 

 
153,322

 

Loss from continuing operations
(154,265
)
 
(30,211
)
 
(21,184
)
 
153,322

 
(52,338
)
Loss from discontinued operations, net of tax

 

 
(144
)
 

 
(144
)
Net loss
(154,265
)
 
(30,211
)
 
(21,328
)
 
153,322

 
(52,482
)
Net loss attributable to noncontrolling interests

 

 
344

 

 
344

Net loss attributable to CME Ltd.
(154,265
)
 
(30,211
)
 
(20,984
)
 
153,322

 
(52,138
)
Comprehensive loss attributable to CME Ltd.
$
(154,265
)
 
$
(150,941
)
 
$
(2,381
)
 
$
153,322

 
$
(154,265
)
Condensed Cash Flow Statement
Condensed Consolidating Statements of Cash Flows for the nine months ended September 30, 2014
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net cash (used in) / generated from continuing operating activities
$
(13,808
)
 
$
(34,282
)
 
$
29,673

 
$

 
$
(18,417
)
 
 
 
 
 
 
 
 
 
 
CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of property, plant and equipment

 

 
(20,376
)
 

 
(20,376
)
Disposal of property, plant and equipment

 

 
162

 

 
162

Intercompany investing receipts
342,908

 
41,186

 

 
(384,094
)
 

Intercompany investing payments
(362,740
)
 
(30,671
)
 

 
393,411

 

Net cash (used in) / provided by continuing investing activities
(19,832
)
 
10,515

 
(20,214
)
 
9,317

 
(20,214
)
 
 
 
 
 
 
 
 
 
 
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Repayments of Senior Debt
(400,673
)
 

 

 

 
(400,673
)
Debt transaction costs
(11,185
)
 

 
(1,594
)
 

 
(12,779
)
Issuance of Senior Debt
221,374

 

 

 

 
221,374

Proceeds from credit facilities
16,801

 

 
23

 

 
16,824

Payment of credit facilities and capital leases

 

 
(1,370
)
 

 
(1,370
)
Issuance of common stock warrants

191,825

 

 

 

 
191,825

Dividends paid to holders of noncontrolling interests

 

 
(46
)
 

 
(46
)
Intercompany financing receipts

 
362,740

 
30,671

 
(393,411
)
 

Intercompany financing payments

 
(342,908
)
 
(41,186
)
 
384,094

 

Net cash provided by / (used in) continuing financing activities
18,142

 
19,832

 
(13,502
)
 
(9,317
)
 
15,155

 
 
 
 
 
 
 
 
 
 
Net cash used in discontinued operations - operating activities

 

 
(673
)
 

 
(673
)
Net cash used in discontinued operations - financing activities

 

 
(107
)
 

 
(107
)
 
 
 
 
 
 
 
 
 
 
Impact of exchange rate fluctuations on cash

 
(62
)
 
(6,625
)
 

 
(6,687
)
Net decrease in cash and cash equivalents
(15,498
)
 
(3,997
)
 
(11,448
)
 

 
(30,943
)
CASH AND CASH EQUIVALENTS, beginning of period
19,461

 
5,422

 
78,741

 

 
103,624

CASH AND CASH EQUIVALENTS, end of period
$
3,963

 
$
1,425

 
$
67,293

 
$

 
$
72,681

Condensed Consolidating Statements of Cash Flows for the nine months ended September 30, 2013
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net cash (used in) / generated from continuing operating activities
$
(63,923
)
 
$
225,141

 
$
(215,953
)
 
$

 
$
(54,735
)
 
 
 
 
 
 
 
 
 
 
CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of property, plant and equipment

 

 
(20,884
)
 

 
(20,884
)
Disposal of property, plant and equipment

 

 
246

 

 
246

Intercompany investing receipts
566,193

 
9,323

 

 
(575,516
)
 

Intercompany investing payments
(544,769
)
 
(205,886
)
 

 
750,655

 

Net cash provided by / (used in) continuing investing activities
21,424

 
(196,563
)
 
(20,638
)
 
175,139

 
(20,638
)
 
 
 
 
 
 
 
 
 
 
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Repayments of Senior Debt
(310,322
)
 

 

 

 
(310,322
)
Debt transactions costs
(639
)
 

 
(146
)
 

 
(785
)
Change in restricted cash
20,467

 

 

 

 
20,467

Proceeds from credit facilities

 

 
826

 

 
826

Payment of credit facilities and capital leases

 

 
(1,715
)
 

 
(1,715
)
Issuance of common stock
157,116

 

 

 

 
157,116

Issuance of preferred stock
200,000

 

 

 

 
200,000

Equity issuance costs
(5,410
)
 

 

 

 
(5,410
)
Dividends paid to holders of noncontrolling interests

 

 
(273
)
 

 
(273
)
Intercompany financing receipts

 
544,769

 
205,886

 
(750,655
)
 

Intercompany financing payments

 
(566,193
)
 
(9,323
)
 
575,516

 

Net cash provided by / (used in) financing activities
61,212

 
(21,424
)
 
195,255

 
(175,139
)
 
59,904

 
 
 
 
 
 
 
 
 
 
Net cash used in discontinued operations - operating activities

 

 
(1,047
)
 

 
(1,047
)
Net cash provided by discontinued operations - financing activities

 

 
273

 

 
273

 
 
 
 
 
 
 
 
 
 
Impact of exchange rate fluctuations on cash

 
139

 
(573
)
 

 
(434
)
Net increase / (decrease) in cash and cash equivalents
18,713

 
7,293

 
(42,683
)
 

 
(16,677
)
CASH AND CASH EQUIVALENTS, beginning of period
9,372

 
2,836

 
126,471

 

 
138,679

CASH AND CASH EQUIVALENTS, end of period
$
28,085

 
$
10,129

 
$
83,788

 
$

 
$
122,002